Modifed Blalock-Taussig Shunts for Patients with Congenital Heart Diseases of Diminutive Pulmonary Blood_Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Authors：

XUZhao-Jun ¹ ,  SONGLan ² , YINXiao-Qing ¹ , WANGZhao-li ¹ , YANGJin ¹ , CHENGYu ¹ , XIEXin-long ¹ , ZHANGSheng-kang ¹ , HUANGWen-juan ¹

1. Department of Cardiothoracic Surgery, te First Afliated Hospital, Hunan University of Chinese Medicine, Changsha 410007, P. R. China;
2. Department of Biochemistry and Molecular Biology, Hunan University of Chinese Medicine, Changsha 410208, P. R. China;

Corresponding?author：

SONGLan, Email: songlan311492@163.com

Keywords：

Modified Blalock-Taussig shunts; Congenital heart diseases; Palliative operation

DOI：

10.7507/1007-4848.20150118

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To evaluate the surgical outcomes of modified Blalock-Taussig shunts in the patients with congenital heart diseases of diminutive pulmonary blood. Methods We retrospectively analyzed the clinical data of 39 patients with congenital heart diseases of diminutive pulmonary blood, who underwent modified Blalock-Taussig shunts with Gore-Tex vessels in the First Affiliated Hospital, Hunan University of Chinese Medicine between June 2007 and June 2013. There were 23 male and 16 female patients at age of 6 months to 16 years (4.64±3.85) years, body weigh at 4.5-43.0 (14.81±8.69) kg. Results There were 4 postoperative deaths. The early mortality was 7.69% (3/39). The arterial oxygen saturation increased from 64.28%±8.05% to 81.07%±5.76% (P < 0.01). Ideal pulmonary flow in each patient was obtained. Pulmonary arteries were significantly improved compared with those before operation. McGoon ratio (1.11±0.16 versus 1.58±0.22, P < 0.01) and Nakata index (113.98±14.84 mm²/m² versus 160.98±26.65 mm²/m², P < 0.01) increased with a statistical difference. Two-stage radical operations were performed in 8 patients. Conclusions Modified Blalock-Taussig shunt is effective in promoting development of the pulmonary arteries and improving cyanosis significantly. Modified Blalock-Taussig shunt can correct hypoxia to prepare for the radical operation．

Citation： XUZhao-Jun, SONGLan, YINXiao-Qing, WANGZhao-li, YANGJin, CHENGYu, XIEXin-long, ZHANGSheng-kang, HUANGWen-juan. Modifed Blalock-Taussig Shunts for Patients with Congenital Heart Diseases of Diminutive Pulmonary Blood. Chinese Journal of Clinical Thoracic and Cardiovascular Surgery, 2015, 22(5): 450-453. doi: 10.7507/1007-4848.20150118 Copy

1.	肖海波, 梅舉, 丁寶芳, 等.改良Blalock-Taussig分流術治療復雜發紺型先天性心臟病的效果.實用兒科臨床雜志, 2011, 26(1):19-21.
2.	周誠, 董念國, 杜心靈, 等.姑息性手術在復雜先天性心臟病患者中的應用.中國胸心血管外科臨床雜志, 2012, 19(5):494-497.
3.	汪曾煒, 劉維永, 張寶仁, 主編.心臟外科學.北京:人民軍醫出版社, 2003:878-939.
4.	O'Connor MJ, Ravishankar C, Ballweg JA, et al. Early systemic-topulmonary artery shunt intervention in neonates with congenital heart disease. J Torac Cardiovasc Surg, 2011, 142(1):106-112.
5.	劉金平, 董念國, 孫宗全, 等.非體外循環下復雜先天性心臟病的姑息手術.臨床心血管病雜志, 2010, 26(5):770-772.
6.	鄭景浩, 劉錦紛, 蘇肇伉, 等.體肺分流術在小兒復雜先天性心臟病手術中的應用.中華胸心血管外科雜志, 2005, 12(6):371.
7.	Fenton KN, Siewers RD, Rebovich B, et al. Interim mortality in infants with systemic-to-pulmonary artery shunts. Ann Thorac Surg, 2003, 76(1):152-157.
8.	方敏華, 王輝山, 汪曾煒, 等.體-肺動脈分流術后早期分流失效的危險因素分析.中國胸心血管外科臨床雜志, 2012, 19(4):354-357.
9.	徐卓明, 楊琦, 郭林林, 等.先天性心臟病體肺分流術后早期失敗危險因素分析.上海交通大學學報(醫學版), 2011, 31(9):1266-1268.
10.	Gedicke M, Morgan G, Parry A, et al. Risk factors for acute shunt blockage in children afer modified Blalock-Taussig shunt operations. Heart Vessels, 2010, 25(5):405-409.
11.	Petrucci O, O'Brien SM, Jacobs ML, et al. Risk factors for mortality and morbidity afer the neonatal Blalock-Taussig shunt procedure. Ann Torac Surg, 2011, 92(2):642-651.
12.	Sahoo TK, Chauhan S, Sahu M, et al. Effects of hemodilution on outcome after modified Blalock-Taussig shunt operation in children with cyanotic congenital heart disease. J Cardiothorac Vasc Anesth, 2007, 21(2):179-183.
13.	Li JS, Yow E, Berezny KY, et al. Clinical outcomes of palliative surgery including a systemic-to-pulmonary artery shunt in infants with cyanotic congenital heart disease:does aspirin make a difference? Circulation, 2007, 116(3):293-297.
14.	郭林林, 楊琦, 徐卓明, 等.先天性心臟病體肺分流術的療效評估.中華臨床醫師雜志(電子版), 2012, 6(4):52-55.
15.	Amark KM, Karamlou T, O'Carroll A, et al. Independent factors associated with mortality, reintervention, and achievement of complete repair in children with pulmonary atresia with ventricular septal defect. J Am Coll Cardiol, 2006, 47(7):1448-1456.
16.	鄧喜成, 沈向東, 郭少先, 等.姑息手術在肺動脈閉鎖合并室間隔缺損分期矯治中的應用.中國胸心血管外科臨床雜志, 2011, 18(2):104-108.
17.	Seipelt RG, Vazquez-Jimenez JF, Sachweh JS, et al. Antegrade palliation for diminutive pulmonary arteries in Tetralogy of Fallot. Eur J Cardiothorac Surg, 2002, 21(4):721-724.
18.	Kim HK, Kim WH, Kim SC, et al. Surgical strategy for pulmonary coaretation in the univentrieular heart. Eur J Cardiothorac Surg, 2006, 29(1):100-104.

1. 肖海波, 梅舉, 丁寶芳, 等.改良Blalock-Taussig分流術治療復雜發紺型先天性心臟病的效果.實用兒科臨床雜志, 2011, 26(1):19-21.
2. 周誠, 董念國, 杜心靈, 等.姑息性手術在復雜先天性心臟病患者中的應用.中國胸心血管外科臨床雜志, 2012, 19(5):494-497.
3. 汪曾煒, 劉維永, 張寶仁, 主編.心臟外科學.北京:人民軍醫出版社, 2003:878-939.
4. O'Connor MJ, Ravishankar C, Ballweg JA, et al. Early systemic-topulmonary artery shunt intervention in neonates with congenital heart disease. J Torac Cardiovasc Surg, 2011, 142(1):106-112.
5. 劉金平, 董念國, 孫宗全, 等.非體外循環下復雜先天性心臟病的姑息手術.臨床心血管病雜志, 2010, 26(5):770-772.
6. 鄭景浩, 劉錦紛, 蘇肇伉, 等.體肺分流術在小兒復雜先天性心臟病手術中的應用.中華胸心血管外科雜志, 2005, 12(6):371.
7. Fenton KN, Siewers RD, Rebovich B, et al. Interim mortality in infants with systemic-to-pulmonary artery shunts. Ann Thorac Surg, 2003, 76(1):152-157.
8. 方敏華, 王輝山, 汪曾煒, 等.體-肺動脈分流術后早期分流失效的危險因素分析.中國胸心血管外科臨床雜志, 2012, 19(4):354-357.
9. 徐卓明, 楊琦, 郭林林, 等.先天性心臟病體肺分流術后早期失敗危險因素分析.上海交通大學學報(醫學版), 2011, 31(9):1266-1268.
10. Gedicke M, Morgan G, Parry A, et al. Risk factors for acute shunt blockage in children afer modified Blalock-Taussig shunt operations. Heart Vessels, 2010, 25(5):405-409.
11. Petrucci O, O'Brien SM, Jacobs ML, et al. Risk factors for mortality and morbidity afer the neonatal Blalock-Taussig shunt procedure. Ann Torac Surg, 2011, 92(2):642-651.
12. Sahoo TK, Chauhan S, Sahu M, et al. Effects of hemodilution on outcome after modified Blalock-Taussig shunt operation in children with cyanotic congenital heart disease. J Cardiothorac Vasc Anesth, 2007, 21(2):179-183.
13. Li JS, Yow E, Berezny KY, et al. Clinical outcomes of palliative surgery including a systemic-to-pulmonary artery shunt in infants with cyanotic congenital heart disease:does aspirin make a difference? Circulation, 2007, 116(3):293-297.
14. 郭林林, 楊琦, 徐卓明, 等.先天性心臟病體肺分流術的療效評估.中華臨床醫師雜志(電子版), 2012, 6(4):52-55.
15. Amark KM, Karamlou T, O'Carroll A, et al. Independent factors associated with mortality, reintervention, and achievement of complete repair in children with pulmonary atresia with ventricular septal defect. J Am Coll Cardiol, 2006, 47(7):1448-1456.
16. 鄧喜成, 沈向東, 郭少先, 等.姑息手術在肺動脈閉鎖合并室間隔缺損分期矯治中的應用.中國胸心血管外科臨床雜志, 2011, 18(2):104-108.
17. Seipelt RG, Vazquez-Jimenez JF, Sachweh JS, et al. Antegrade palliation for diminutive pulmonary arteries in Tetralogy of Fallot. Eur J Cardiothorac Surg, 2002, 21(4):721-724.
18. Kim HK, Kim WH, Kim SC, et al. Surgical strategy for pulmonary coaretation in the univentrieular heart. Eur J Cardiothorac Surg, 2006, 29(1):100-104.

Chinese Journal of Clinical Thoracic and Cardiovascular Surgery

Modifed Blalock-Taussig Shunts for Patients with Congenital Heart Diseases of Diminutive Pulmonary Blood

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content